Position in CGC
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$9,576
-$3,597 QoQ
Shares Held
10,091
-12.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in CGC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Private Advisor Group, LLC holds $12,585,036 across 16 Drug Manufacturers - Specialty & Generic names. CGC ranks #16 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
185,024 | $4,427,624 | |
| 2 | HLN |
Haleon plc
|
219,187 | $2,194,061 | |
| 3 | ZTS |
Zoetis Inc.
|
15,150 | $1,790,881 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
42,625 | $884,895 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
21,888 | $659,266 | |
| 6 | VTRS |
Viatris Inc
|
41,557 | $561,435 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
890 | $527,752 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
26,488 | $490,557 |
All Filings in CGC
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,576 | 10,091 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $13,173 | 11,556 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $17,660 | 12,096 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $12,895 | 10,570 | Shares | Sole | 2025-08-11 | |
| 2024-09-30 | $61,459 | 12,751 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $70,259 | 10,893 | Shares | Sole | 2024-08-05 | |
| 2023-12-31 | $70,272 | 13,752 | Shares | Sole | 2024-02-06 | |
| No filing history on record for this holder in this stock. | ||||||